Correlation Engine 2.0
Clear Search sequence regions


  • ABCB1 (1)
  • ABCC5 (2)
  • antimetabolites (2)
  • ATP (2)
  • balb c mice (2)
  • cancer (2)
  • cancer stem cell (1)
  • carcinogen (1)
  • cell membrane (2)
  • cellular (1)
  • colon (3)
  • colon cancer (3)
  • colon carcinoma (3)
  • dextran (3)
  • fish oil (11)
  • fluorouracil (11)
  • fluorouracil (2)
  • humans (1)
  • liver (1)
  • mice (1)
  • n 3 pufas (2)
  • serum (1)
  • sodium (1)
  • spleen (1)
  • stem cells (1)
  • Sizes of these terms reflect their relevance to your search.

    Latest strategies for cancer treatment primarily focus on the use of chemosensitizers to enhance therapeutic outcome. N-3 PUFAs have emerged as the strongest candidate for the prevention of colorectal cancer (CRC). Our previous studies have demonstrated that fish oil (FO) rich in n-3 PUFAs not only increased therapeutic potential of 5-Fluorouracil(5-FU) in colon cancer but also ameliorated its toxicity. Henceforth, the present study is designed to elucidate mechanistic insights of FO as a chemosensitizer to circumvent drug resistance in experimental colon carcinoma. The colon cancer was induced by 1,2-dimethylhydrazine(DMH)/dextran sulfate sodium(DSS) in male Balb/c mice and these animals were treated with 5-FU(12.5 mg/kg b.w.), FO(0.2 ml), or 5-FU + FO(12.5 mg/kg b.w + 0.2 ml) orally for 14 days. The molecular mechanism of overcoming 5-FU resistance using FO in colon cancer was delineated by estimating expression of cancer stem cell markers using flowcytometric method and drug transporters by immunohistochemistry and immunoblotting. Additionally, distribution profile of 5-FU and its cytotoxic metabolite, 5-FdUMP at target(colon), and non-target sites (serum, kidney, liver, spleen) was assessed using high-performance liquid chromatography(HPLC) method. The observations revealed that expression of CSCs markers was remarkably reduced after using fish oil along with 5-FU in carcinogen-treated animals. Interestingly, the use of FO alongwith 5-FU also significantly declined the expression of drug transporters (ABCB1,ABCC5) and consequently resulted in an increased cellular uptake of 5-FU and its metabolite, 5-FdUMP at target site (colon). It could be possibly associated with change in permeability of cell membrane owing to the alteration in membrane fluidity. The present study revealed the mechanistic insights of FO as a MDR revertant which successfully restored 5-FU-mediated chemoresistance in experimental colon carcinoma.

    Citation

    Isha Rani, Sandeep Kumar, Bhoomika Sharma, Rajendra Prasad, Satinder Kaur, Prerna Sharma, Navneet Agnihotri. Elucidation of underlying molecular mechanism of 5-Fluorouracil chemoresistance and its restoration using fish oil in experimental colon carcinoma. Molecular and cellular biochemistry. 2021 Mar;476(3):1517-1527

    Expand section icon Mesh Tags

    Expand section icon Substances


    PMID: 33392922

    View Full Text